Eijsvogels, Thijs M. H.
Thompson, Paul D.
Franklin, Barry A.
Funding for this research was provided by:
Radboud University Medical Center
Article History
First Online: 28 August 2018
Compliance with Ethical Standards
:
: Thijs M.H. Eijsvogels and Barry A. Franklin each declare no potential conflicts of interest.Paul D. Thompson reports being a member of the Speakers’ Bureau for Regeneron, Sanofi, Amgen and Amarin; serving as a consultant for Amgen, Regeneron, Esperion and Sanolfi; receiving research support from Sanofi, Regeneron, Esperion, Amgen, and Amarin; owning stock in Abbvie, Abbott, CVS, General Electric, Johnson & Johnson, Medtronic, and Sarepta; and providing legal consultation on exercise-related cardiac events and statin myopathy.
: This article does not contain any studies with human or animal subjects performed by any of the authors.